keyword
https://read.qxmd.com/read/38564514/effects-of-the-covid-19-pandemic-on-hiv-service-delivery-and-viral-suppression-findings-from-the-sharp-program-in-northern-nigeria
#21
JOURNAL ARTICLE
Cyrus Mugo, Oluwasanmi Adedokun, Oluwafemi David Alo, Nnenna Ezeokafor, Sylvester Adeyemi, Zipporah Kpamor, Leila Madueke, Ezekiel James, Sylvia Bolanle Adebajo, Bazghina-Werq Semo
During the COVID-19 pandemic, HIV programs scaled up differentiated service delivery (DSD) models for people living with HIV (PLHIV). We evaluated the effects of COVID-19 on HIV service delivery and viral suppression in facilities in Northern Nigeria, and determined factors associated with viral suppression among adolescents and adults. We analysed a cross-sectional survey data from facility heads, and retrospective, routinely collected patient data from 63 facilities for PLHIV ≥10 years old in care between April 2019-March 2021, defining study periods as "pre-COVID-19" (before April 2020) and "during COVID-19" (after April 2020)...
2024: PloS One
https://read.qxmd.com/read/38561995/the-effects-of-citrus-flavonoids-supplementation-on-endothelial-function-a-systematic-review-and-dose-response-meta-analysis-of-randomized-clinical-trials
#22
JOURNAL ARTICLE
Farnaz Jalili, Sajjad Moradi, Sepide Talebi, Sanaz Mehrabani, Seyed Mojtaba Ghoreishy, Alexei Wong, Ali R Jalalvand, Mohammad Ali Hojjati Kermani, Cyrus Jalili, Faramarz Jalili
The present systematic review and dose-response meta-analysis was conducted to synthesize existing data from randomized clinical trials (RCTs) concerning the impact of citrus flavonoids supplementation (CFS) on endothelial function. Relevant RCTs were identified through comprehensive searches of the PubMed, ISI Web of Science, and Scopus databases up to May 30, 2023. Weighted mean differences and their corresponding 95% confidence intervals (CI) were pooled utilizing a random-effects model. A total of eight eligible RCTs, comprising 596 participants, were included in the analysis...
April 1, 2024: Phytotherapy Research: PTR
https://read.qxmd.com/read/38557443/rev7-p53-interaction-inhibits-atm-mediated-dna-damage-signaling
#23
JOURNAL ARTICLE
Megan Biller, Sara Kabir, Chkylle Boado, Sarah Nipper, Alexandra Saffa, Ariella Tal, Sydney Allen, Hiroyuki Sasanuma, Didier Dréau, Cyrus Vaziri, Junya Tomida
REV7 is an abundant, multifunctional protein that is a known factor in cell cycle regulation and in several key DNA repair pathways including Trans-Lesion Synthesis (TLS), the Fanconi Anemia (FA) pathway, and DNA Double-Strand Break (DSB) repair pathway choice. Thus far, no direct role has been studied for REV7 in the DNA damage response (DDR) signaling pathway. Here we describe a novel function for REV7 in DSB-induced p53 signaling. We show that REV7 binds directly to p53 to block ATM-dependent p53 Ser15 phosphorylation...
April 1, 2024: Cell Cycle
https://read.qxmd.com/read/38556375/editorial-comment
#24
JOURNAL ARTICLE
Cyrus Chehroudi, Smita De
No abstract text is available yet for this article.
March 30, 2024: Urology
https://read.qxmd.com/read/38555928/the-safety-and-immunogenicity-of-a-bivalent-conjugate-vaccine-against-salmonella-enterica-typhi-and-paratyphi-a-in-healthy-indian-adults-a-phase-1-randomised-active-controlled-double-blind-trial
#25
JOURNAL ARTICLE
Prasad S Kulkarni, Anirudha Vyankatesh Potey, Sandesh Bharati, Anil Kunhihitlu, Bharath Narasimha, Sindhu Yallapa, Abhijeet Dharmadhikari, Vinay Gavade, Chandrashekhar D Kamat, Asha Mallya, Annamraju D Sarma, Sunil Goel, Sambhaji S Pisal, Cyrus S Poonawalla, Rajaram Venkatesan, Elizabeth Jones, Amy Flaxman, Young Chan Kim, Andrew J Pollard
BACKGROUND: Enteric fever caused by Salmonella enterica Typhi and Salmonella Paratyphi A is an important public health problem, especially in low-income and middle-income countries with limited access to safe water and sanitation. We present results from, to our knowledge, the first ever human study of a bivalent paratyphoid A-typhoid conjugate vaccine (Sii-PTCV). METHODS: In this double-blind phase 1 study, 60 healthy Indian adults were randomly assigned (1:1) to receive a single intramuscular dose of either Sii-PTCV or typhoid conjugate vaccine (Typbar-TCV)...
March 28, 2024: Lancet
https://read.qxmd.com/read/38549492/riding-the-wave-of-change-providing-solid-ground-to-support-nursing-with-patient-transitions-to-novel-haemophilia-therapies
#26
JOURNAL ARTICLE
Erica Crilly, Cathy Harrison, Jennifer Maahs, Marlene Beijlevelt, Brian Ramsay, Cyrus Githinji, Marcela Sisdelli, Anjalin Dsouza
INTRODUCTION: Haemophilia nursing practice has experienced a shift in the past decade, as the historic chief focus on factor infusions shifted to extended half-life products, bispecific antibody therapies and other non-replacement therapies. This evolution has driven a need for changes in nursing practice in many haemophilia treatment centres. AIM: This article intends to provide insights to the haemophilia nurse to champion practice changes at their haemophilia treatment centres...
March 29, 2024: Haemophilia: the Official Journal of the World Federation of Hemophilia
https://read.qxmd.com/read/38546877/melittin-phospholipase-a-2-synergism-is-mediated-by-liquid-liquid-miscibility-phase-transition-in-giant-unilamellar-vesicles
#27
JOURNAL ARTICLE
Sein Min, Cyrus Picou, Hye Jin Jeong, Adam Bower, Keunhong Jeong, Jean K Chung
The primary constituents of honeybee venom, melittin and phospholipase A2 (PLA2 ), display toxin synergism in which the PLA2 activity is significantly enhanced by the presence of melittin. It has been shown previously that this is accomplished by the disruption in lipid packing, which allows PLA2 to become processive on the membrane surface. In this work, we show that melittin is capable of driving miscibility phase transition in giant unilamellar vesicles (GUVs) and that it raises the miscibility transition temperature ( T misc ) in a concentration-dependent manner...
March 28, 2024: Langmuir: the ACS Journal of Surfaces and Colloids
https://read.qxmd.com/read/38546381/thrombopoietin-receptor-agonists-and-other-second-line-therapies-for-immune-thrombocytopenia-a-narrative-review-with-a-focus-on-drug-access-in-canada
#28
REVIEW
Joanne Britto, Anne Holbrook, Haowei Sun, Christine Cserti-Gazdewich, Oksana Prokopchuk-Gauk, Cyrus Hsia, Karima Khamisa, Paul R Yenson, Michelle Sholzberg, Harold J Olney, Sudeep Shivakumar, David Jones, Hayley Merkeley, Jacqueline Costello, Erin Jamula, Donald M Arnold
INTRODUCTION: Immune thrombocytopenia (ITP) is an autoimmune disease characterized by low platelet counts and increased risk of bleeding. After corticosteroids with or without intravenous immune globulin (first-line treatment), second-line treatment options include rituximab, splenectomy, thrombopoietin receptor agonists (TPO-RAs), and fostamatinib. In Canada, the choice of second-line therapy is influenced by access to medications. The goals of this narrative review are to 1) summarize the evidence for the use of TPO-RAs and other second-line therapies in ITP and 2) highlight differences in public funding criteria for TPO-RAs across provinces and territories in Canada...
March 1, 2024: Clinical and Investigative Medicine. Médecine Clinique et Experimentale
https://read.qxmd.com/read/38543880/poliovirus-neutralizing-antibody-seroprevalence-and-vaccine-habits-in-a-vaccine-derived-poliovirus-outbreak-region-in-the-democratic-republic-of-congo-in-2018-the-impact-on-the-global-eradication-initiative
#29
JOURNAL ARTICLE
Megan Halbrook, Adva Gadoth, Patrick Mukadi, Nicole A Hoff, Kamy Musene, Camille Dzogang, Cyrus Shannon Sinai, D'Andre Spencer, Guillaume Ngoie-Mwamba, Sylvia Tangney, Frank Salet, Michel Nyembwe, Michel Kambamba Nzaji, Merly Tambu, Placide Mbala, Trevon Fuller, Sue K Gerber, Didine Kaba, Jean Jacques Muyembe-Tamfum, Anne W Rimoin
Despite the successes in wild-type polio eradication, poor vaccine coverage in the DRC has led to the occurrence of circulating vaccine-derived poliovirus outbreaks. This cross-sectional population-based survey provides an update to previous poliovirus-neutralizing antibody seroprevalence studies in the DRC and quantifies risk factors for under-immunization and parental knowledge that guide vaccine decision making. Among the 964 children between 6 and 35 months in our survey, 43.8% (95% CI: 40.6-47.0%), 41...
February 27, 2024: Vaccines
https://read.qxmd.com/read/38541377/barriers-to-accessing-and-engaging-in-hiv-preventive-care-and-pre-exposure-prophylaxis-experienced-by-transgender-women-in-florida
#30
JOURNAL ARTICLE
Allysha C Maragh-Bass, Sandra Kiplagat, Sarah Lavari, Francisco Sastre, Jessy G Devieux, Daniel Jimenez, Rachel D Clarke, Ines Noel, Eric W Schrimshaw, Jae Sevelius, Elena Cyrus
BACKGROUND: PrEP, a biomedical HIV prevention option, continues to be underutilized among transgender women who could benefit from sustained use, especially women of color and those who identify as Latina and/or reside in the southeastern US. OBJECTIVE: We explored the barriers and facilitators experienced by transgender women who live in Florida regarding accessing, using, and/or staying on PrEP. METHODS: In-depth interviews and focus groups were conducted in either Spanish or English with adult transgender women living in Florida (N = 22)...
March 21, 2024: International Journal of Environmental Research and Public Health
https://read.qxmd.com/read/38524863/nutritional-status-link-with-polioseronegativity-among-children-from-poliomyelitis-transmission-high-risk-area-of-the-democratic-republic-of-the-congo-drc
#31
JOURNAL ARTICLE
Guillaume N Mwamba, Michel Kabamba Nzaji, Nicole A Hoff, Patrick K Mukadi, Kamy Kaminye Musene, Sue K Gerber, Megan Halbrook, Cyrus Sinai, Trevon Fuller, Oscar Luboya Numbi, Emile Okitolonda Wemakoy, Jean Jacques Muyembe Tamfum, Dalau Nkamba Mukadi, Mala Ali Mapatano, Anne W Rimoin, Paul-Samson Lusamba Dikassa
BACKGROUND: Malnutrition is identified as a risk-factor for insufficient polioseroconversion in the context of a vaccine-derived polio virus (VDPV) outbreak prone region. To assess the prevalence of malnutrition and its link to poliovirus insufficient immunity, a cross-sectional household survey was conducted in the regions of Haut- Lomami and Tanganyika, DRC. METHODS: In March 2018, we included 968 healthy children aged 6 to 59 months from eight out of 27 districts...
2024: Journal of Multidisciplinary Healthcare
https://read.qxmd.com/read/38521653/poised-epigenetic-states-dictate-metastatic-fitness
#32
JOURNAL ARTICLE
Rebeka Tomasin, Cyrus M Ghajar
Seeking to define early events that regulate disseminated tumor cell (DTC) fate upon their arrival to the lung, Jakab et al. reach the surprising conclusion that dormancy is determined by a cell autonomous poised epigenetic state that renders DTCs responsive to angiocrine Wnt signaling.
March 22, 2024: Trends in Cancer
https://read.qxmd.com/read/38521217/you-can-and-should-specialize-in-global-neurosurgery
#33
JOURNAL ARTICLE
Cyrus Elahi
No abstract text is available yet for this article.
March 21, 2024: World Neurosurgery
https://read.qxmd.com/read/38520141/the-conceptual-definition-of-sarcopenia-delphi-consensus-from-the-global-leadership-initiative-in-sarcopenia-glis
#34
JOURNAL ARTICLE
Ben Kirk, Peggy M Cawthon, Hidenori Arai, José A Ávila-Funes, Rocco Barazzoni, Shalender Bhasin, Ellen F Binder, Olivier Bruyere, Tommy Cederholm, Liang-Kung Chen, Cyrus Cooper, Gustavo Duque, Roger A Fielding, Jack Guralnik, Douglas P Kiel, Francesco Landi, Jean-Yves Reginster, Avan A Sayer, Marjolein Visser, Stephan von Haehling, Jean Woo, Alfonso J Cruz-Jentoft
IMPORTANCE: Sarcopenia, the age-related loss of muscle mass and strength/function, is an important clinical condition. However, no international consensus on the definition exists. OBJECTIVE: The Global Leadership Initiative in Sarcopenia (GLIS) aimed to address this by establishing the global conceptual definition of sarcopenia. DESIGN: The GLIS steering committee was formed in 2019-21 with representatives from all relevant scientific societies worldwide...
March 1, 2024: Age and Ageing
https://read.qxmd.com/read/38512600/literature-review-mechanism-indications-and-clinical-efficacy-of-peripheral-nerve-stimulators-in-lower-extremity-pain
#35
REVIEW
Qing Zhao Ruan, Jason Chang, Daniel Pak, Rajesh Supra, Cyrus Yazdi, Linda Kollenburg, Erkan Kurt, David Reece, Alexandra C G Fonseca, Alaa Abd-Elsayed, Christopher L Robinson
PURPOSE OF REVIEW: Lower extremity pain is deemed by Center for Disease Control and Prevention (CDC) to be a significant source of chronic pain in adults. If not appropriately managed, patients are subjected to risks of prolonged musculoskeletal dysfunction, disruption to quality of life, and elevated healthcare expenditures. Peripheral nerve stimulation (PNS) has shown great potential in recent years demonstrating efficacy in multiple diagnoses ranging from acute post-surgical pain to complex regional pain syndrome (CRPS)...
March 21, 2024: Current Pain and Headache Reports
https://read.qxmd.com/read/38512394/seropersistence-of-sii-chadox1-ncov-19-covid-19-vaccine-6-month-follow-up-of-a-randomized-controlled-observer-blind-phase-2-3-immuno-bridging-study-in-indian-adults
#36
RANDOMIZED CONTROLLED TRIAL
Prasad S Kulkarni, Chandrasekaran Padmapriyadarsini, Johan Vekemans, Ashish Bavdekar, Madhu Gupta, Praveen Kulkarni, B S Garg, Nithya J Gogtay, Muralidhar Tambe, Sanjay Lalwani, Kiranjit Singh, Renuka Munshi, Sushant Meshram, T S Selvavinayagam, Krishna Pandey, Devi Madhavi Bhimarasetty, S R Ramakrishnan, Chetanraj Bhamare, Abhijeet Dharmadhikari, Chandrashekhar Budhawant, Cyrille J Bonhomme, Madhuri Thakar, Swarali N Kurle, Elizabeth J Kelly, Manish Gautam, Nivedita Gupta, Samiran Panda, Balram Bhargava, Cyrus S Poonawalla, Umesh Shaligram, Dhananjay Kapse, Bhagwat Gunale
AZD1222 (ChAdOx1 nCoV-19) is a replication-deficient adenoviral vectored coronavirus disease-19 (COVID-19) vaccine that is manufactured as SII-ChAdOx1 nCoV-19 by the Serum Institute of India Pvt Ltd following technology transfer from Oxford University/AstraZeneca. The non-inferiority of SII-ChAdOx1 nCoV-19 with AZD1222 was previously demonstrated in an observer-blind, phase 2/3 immuno-bridging study (trial registration: CTRI/2020/08/027170). In this analysis of immunogenicity and safety data 6 months post first vaccination (Day 180), 1,601 participants were randomized 3:1 to SII-ChAdOx1 nCoV-19 or AZD1222 (immunogenicity/reactogenicity cohort n  = 401) and 3:1 to SII-ChAdOx1 nCoV-19 or placebo (safety cohort n  = 1,200)...
December 31, 2024: Human Vaccines & Immunotherapeutics
https://read.qxmd.com/read/38512295/nonverbal
#37
JOURNAL ARTICLE
Cyrus Ayubcha
No abstract text is available yet for this article.
March 21, 2024: JAMA Oncology
https://read.qxmd.com/read/38509402/early-real-world-implant-experience-with-a-helix-fixation-ventricular-leadless-pacemaker
#38
JOURNAL ARTICLE
Devi G Nair, Derek V Exner, Vivek Y Reddy, Nima Badie, David Ligon, Marc A Miller, Bridget Lee, Brandon Doty, Athanasios Thomaides, Zayd Eldadah, Malick Islam, Cyrus Hadadi
BACKGROUND: Roughly one in six patients receiving conventional transvenous pacemaker systems experience significant complications within 1 year of implant, mainly due to the transvenous lead and subcutaneous pocket. A new helix-fixation single-chamber ventricular leadless pacemaker (LP) system capable of pre-deployment exploratory electrical mapping is commercially available. Such an LP may mitigate complications while streamlining the implantation. In this study, the initial real-world implant experience of the helix-fixation LP was evaluated following its commercial release...
March 20, 2024: Journal of Interventional Cardiac Electrophysiology: An International Journal of Arrhythmias and Pacing
https://read.qxmd.com/read/38508656/circular-rna-as-a-source-of-neoantigens-for-cancer-vaccines
#39
JOURNAL ARTICLE
Yi Ren, Thamizhanban Manoharan, Beijia Liu, Cyrus Zai Ming Cheng, Bei En Siew, Wai-Kit Cheong, Kai Yin Lee, Ian Jse-Wei Tan, Bettina Lieske, Ker-Kan Tan, Gloryn Chia
BACKGROUND: The effectiveness of somatic neoantigen-based immunotherapy is often hindered by the limited number of mutations in tumors with low to moderate mutation burden. Focusing on microsatellite-stable colorectal cancer (CRC), this study investigates the potential of tumor-associated circular RNAs (circRNAs) as an alternative source of neoepitopes in CRC. METHODS: Tumor-associated circRNAs in CRC were identified using the MiOncoCirc database and ribo-depletion RNA sequencing of paired clinical normal and tumor samples...
March 19, 2024: Journal for Immunotherapy of Cancer
https://read.qxmd.com/read/38508473/the-influence-of-indole-propionic-acid-on-molecular-markers-of-steroidogenesis-er-stress-and-apoptosis-in-rat-granulosa-cells-exposed-to-high-glucose-conditions
#40
JOURNAL ARTICLE
Touraj Zamir Nasta, Mohammad Reza Tabandeh, Komail Amini, Ardeshir Abbasi, Dian Dayer, Cyrus Jalili
Hyperglycemia is known as one of the main causes of infertility in human societies. Indole propionic acid (IPA) is produced by intestinal microbiota and has antioxidant and anti-inflammatory properties. This study aims to investigate the effects of IPA on molecular indices of steroidogenesis, ER stress, and apoptosis induced by high glucose (HG) in granulosa cells. Primary GCs, isolated from ovarian follicles of Rats were cultured in 5mM (control) and 30mM (HG) of glucose and in the presence of 10 and 20µM of IPA for 24h...
March 18, 2024: Journal of Steroid Biochemistry and Molecular Biology
keyword
keyword
23489
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.